May 1, 2014
Risk Management in Financing of Capital Expansions
BioVectra Inc. is an eastern Canadian contract manufacturing organization (CMO) with expertise in both synthetic chemistry and biomanufacturing techniques. In recent years, it has obtained specialized knowledge in the production of highly potent small molecules from fermentation and functionalized methoxy-poly (ethylene glycol) products (MPEGs). The focus of BioVectra’s contract manufacturing business is the transfer and scale-up of processes for manufacturing its clients’ products under current good manufacturing practices (cGMPs) as appropriate for the clinical stage of each product.